#NSE0015 Mainboard IPO- Indegene Digital-first life sciences commercialization company | Indegene
The company is raising a total of Rs 1,841.76 crores, combining both a fresh issue of shares and an offer for sale. This is when a company issues new shares to the public to raise capital. In Indegene’s case, they are issuing 1.68 crore new shares to raise Rs 760 crores. This involves selling existing shares held by current shareholders to the public without raising new capital. For Indegene, the offer for sale consists of 2.39 crore shares, aggregating to Rs 1,081.76 crores.
Overall IPO Structure:
- Total Amount: Rs 1,841.76 crores
- Fresh Issue: Rs 760 crores from 1.68 crore shares
- Offer for Sale: Rs 1,081.76 crores from 2.39 crore shares.
here are the key dates:
- Subscription Opening Date: May 6, 2024 – This is when the IPO will be open for the public to start applying for shares.
- Subscription Closing Date: May 8, 2024 – This is the final day on which applications for the IPO can be submitted. Often, if an IPO is oversubscribed, the closing date could involve a lot of activity as investors rush to place their orders.
- Allotment Date: May 9, 2024 – On this day, shares will be allotted to investors who have applied for the IPO. Not all applicants may receive shares; this depends on the level of oversubscription and the allotment policy outlined in the prospectus.
IPO Pricing and Lot Size
- Price Band: ₹430 to ₹452 per share. Investors need to bid within this range.
- Minimum Lot Size for Retail Investors: 33 shares.
- Minimum Investment for Retail Investors: ₹14,916 (at the upper price band of ₹452 per share).
- Minimum Lot Size for Small and Medium Institutional Investors (sNII): 14 lots, which equals 462 shares.
- Minimum Investment for sNII: ₹208,824 (at the upper price band).
- Minimum Lot Size for Big Non-Institutional Investors (bNII): 68 lots, equaling 2,244 shares.
- Minimum Investment for bNII: ₹1,014,288 (at the upper price band).
Use of Proceeds
- According to Manish Gupta, the Chairman and CEO, a significant portion of the IPO proceeds will be used to repay outstanding debt and the associated interest costs. This financial move is aimed at reducing the company’s leverage and boosting profitability. Decreasing debt levels can lead to lower interest expenses, potentially enhancing the company’s net income and financial health.
Services Offered by Indegene
- Product Development Support:
- Clinical Trials and Data Management: Helping companies design and execute clinical trials, manage data, and navigate regulatory requirements efficiently.
- Research and Development Consultancy: Providing scientific and technical expertise to optimize R&D strategies and processes.
- Market Access and Commercialization:
- Regulatory Affairs: Assisting with obtaining approvals from regulatory bodies like the FDA, EMA, etc., ensuring compliance with global standards.
- Market Entry Strategies: Developing strategies for market analysis, entry, and penetration, tailored to the specific therapeutic areas and geographic markets.
- Growth and Lifecycle Management:
- Sales and Marketing Solutions: Offering digital marketing, sales enablement tools, and analytics to maximize the product’s market presence.
- Patient Engagement Programs: Creating programs that enhance patient adherence and optimize treatment outcomes.
- Post-Market Surveillance and Support: Providing ongoing support to monitor the product’s performance and ensure continuous improvement and compliance with safety regulations.
Disclaimer-
It’s important to note that discussions like are for informational purposes only and should not be taken as specific We are not SEBI registered investment advisor. Whether analyzing a company’s financial health, examining market trends, or discussing technical chart patterns, the goal is to provide insights and perspectives that can help you make more informed decisions according to your own research and investment strategy. Always consider consulting with a financial advisor or conducting thorough personal research before making any investment decisions.
